Loading...
Bevacizumab in the treatment of acute central/hemicentral retinal vein occlusions
Even if bevacizumab is unlicensed, a majority of retina specialists still currently recommends it in retinal vein occlusion-related macular edema. For the first time, the results of our studies showed evidence suggesting that an early treatment administered immediately after the onset of venous occl...
Na minha lista:
| Udgivet i: | Rom J Ophthalmol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Romanian Society of Ophthalmology
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5720126/ https://ncbi.nlm.nih.gov/pubmed/29450339 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|